Triple uptake inhibitors: therapeutic potential in...[Expert Opin ...
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... 2008]; Comparison of the effects of antidepressants and their metabolites on ...
http://www.ncbi.nlm.nih.gov/pubmed/17714023...
|
BioPortfolio - DOV Pharmaceutical - Profile
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... Montana's News Station: Oct 28 2008 9:53PM Matching: dov pharmaceutical ...
http://www.bioportfolio.com/biocorporate/3500-DOV%2BPharmace...
|
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3 ...
2008 Mar;324(3):1111-26. Epub 2007 Dec 18. The triple uptake inhibitor (1R,5S)-( +)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV ...
http://www.ncbi.nlm.nih.gov/pubmed/18089843...
|
BioPortfolio - DOV Pharmaceutical - Profile
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... Neurocrine Biosciences Reports Third Quarter 2008 Results ...
http://www.bioportfolio.com/biocorporate/3500-DOV+Pharmaceut...
|
The triple monoaminergic reuptake inhibitor DOV 21...[Eur ...
2008 Sep 11. [Epub ahead of print] Click here to read Links ... We tested the triple uptake inhibitor (TUI), DOV 216303 (5, 10 and 20 mg/kg) after 1, ...
http://www.ncbi.nlm.nih.gov/pubmed/18789657/...
|
Michele Phelps Phil 2008-02-14T15:11:01Z
Michele Phelps Phil 2008-02-14T15:11:01Z 2001-07-25T16:54:03Z .... 372475 ** triple (5HT/noradrenaline/dopamine) re-uptake inhibitor depression NCE II ...
http://www.gsk.com/investors/product_pipeline/v3.xml...
|
In-vitro and in-vivo characterization of JNJ-7925476, a novel ...
Epub 2008 Apr 10. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor. Aluisio L, Lord B, Barbier AJ, Fraser IC, ...
http://www.ncbi.nlm.nih.gov/pubmed/18499098...
|
Pharmaceutical Collaborations 2008 – an SMi conference
BMS and Albany Molecular Research Inc (AMRI) for triple. reuptake inhibitors. ... AMRI's amine neurotransmitter uptake inhibitor program. ...
http://www.biomedcentral.com/content/pdf/cd-900110.pdf...
|
D-161, a novel pyran-based triple monoamine transporter blocker ...
Epub 2008 May 20. D-161, a novel pyran-based triple monoamine transporter blocker: ... Adrenergic Uptake Inhibitors; Antidepressive Agents; D-161 compound ...
http://www.ncbi.nlm.nih.gov/pubmed/18561912...
|
Product Development Pipeline February
triple (5HT/noradrenaline/dopamine) re-uptake. depression. II. inhibitor ... restless legs syndrome. lll. 2008. Lamictal XR. sodium channel inhibitor ...
http://www.gsk.com/investors/product_pipeline/docs/gsk-pipel...
|